Trial Profile
The Role of SAtivex Associated With Robotic-Rehabilitation in Improving the Motor Performances of Multiple Sclerosis Patients (SARR)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary) ; Antispastics
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms SARR
- 25 Jul 2019 Status changed from recruiting to completed.
- 16 Jun 2017 New trial record